'Times' editor to be treated for tumour
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The Editor of The Times, Peter Stothard, told staff on the newspaper yesterday that he will be absent for several months undergoing chemotherapy treatment for a tumour.
News International, which owns The Times, confirmed that Mr Stothard has a tumour of the pancreas that is not cancerous. "He will be back editing in a few months," a spokeswoman said.
Mr Stothard's imminent absence had caused speculation over whether he was out of favour with the newpaper's proprietor, Rupert Murdoch, despite the fact that The Times and its editor recently won two top journalism prizes at the What the Papers Say awards.
Mr Stothard said yesterday: "I felt this was a private matter between Sally [his wife], me and our children, but as a journalist I should have known better." He said he decided to reveal the health problem when The Guardian speculated that his leave was related to the paper's dispute with Michael Ashcroft, the Tory party treasurer.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments